PRF Technologies Ltd. Ordinary Shares (PRFX)

Price$2.64

Favorite Metrics

Price vs S&P 500 (26W)-66.88%

Price vs S&P 500 (4W)10.24%

Market Capitalization$2.31M

All Metrics

Book Value / Share (Quarterly)$20.97

P/TBV (Annual)0.30x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-14.80

Price vs S&P 500 (YTD)-19.09%

EPS (TTM)$-166.27

10-Day Avg Trading Volume2.91M

EPS Excl Extra (TTM)$-166.27

EPS (Annual)$-160.82

ROI (Annual)-799.78%

Cash / Share (Quarterly)$8.64

ROA (Last FY)-322.39%

EBITD / Share (TTM)$-65.50

ROE (5Y Avg)-214.62%

Cash Flow / Share (Annual)$-42.93

P/B Ratio0.27x

P/B Ratio (Quarterly)0.34x

Net Income / Employee (Annual)$-7

Net Interest Coverage (TTM)-361.00x

ROA (TTM)-215.52%

EPS Incl Extra (Annual)$-160.82

Current Ratio (Annual)1.81x

Quick Ratio (Quarterly)1.53x

3-Month Avg Trading Volume0.69M

52-Week Price Return-72.56%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$3.29

52-Week High$17.95

EPS Excl Extra (Annual)$-160.82

26-Week Price Return-58.13%

Quick Ratio (Annual)1.80x

13-Week Price Return-33.90%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.59x

Enterprise Value$-1.174

Revenue / Employee (Annual)$0

Cash / Share (Annual)$14.48

3-Month Return Std Dev124.20%

Net Income / Employee (TTM)$-8

ROE (Last FY)-799.78%

EPS Basic Excl Extra (Annual)$-160.82

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-166.27

Receivables Turnover (Annual)0.00x

ROI (TTM)-329.29%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$10.36

Price vs S&P 500 (52W)-107.66%

Year-to-Date Return-14.95%

5-Day Price Return-0.36%

EPS Normalized (Annual)$-160.82

ROA (5Y Avg)-109.71%

Month-to-Date Return34.81%

Cash Flow / Share (TTM)$-9.03

EBITD / Share (Annual)$-161.74

ROI (5Y Avg)-214.62%

EPS Basic Excl Extra (TTM)$-166.27

P/TBV (Quarterly)2.19x

P/B Ratio (Annual)1.61x

Book Value / Share (Annual)$6.20

Price vs S&P 500 (13W)-36.76%

Beta1.05x

Revenue / Share (TTM)$0.00

ROE (TTM)-329.29%

52-Week Low$1.80

Analyst Recommendations

Mar 2025

Apr 2025

May 2025

Jun 2025

2.17

About

PRF Technologies Ltd is a diversified platform company operating in specialty pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. It specializes in reformulated and sustained-release drug therapies, with PRF-110—its lead candidate based on ropivacaine—targeting the postoperative pain relief market.